0001209191-21-055140.txt : 20210908 0001209191-21-055140.hdr.sgml : 20210908 20210908162243 ACCESSION NUMBER: 0001209191-21-055140 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210907 FILED AS OF DATE: 20210908 DATE AS OF CHANGE: 20210908 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Alland Leila CENTRAL INDEX KEY: 0001825216 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39539 FILM NUMBER: 211242368 MAIL ADDRESS: STREET 1: C/O PMV PHARMACEUTICALS, INC. STREET 2: 8 CLARKE DRIVE, SUITE 3 CITY: CRANBURY STATE: NJ ZIP: 08512 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PMV Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001699382 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 463218129 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 8 CLARKE DRIVE CITY: CRANBURY STATE: NJ ZIP: 08512 BUSINESS PHONE: (609) 642-6664 MAIL ADDRESS: STREET 1: 8 CLARKE DRIVE CITY: CRANBURY STATE: NJ ZIP: 08512 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-09-07 0 0001699382 PMV Pharmaceuticals, Inc. PMVP 0001825216 Alland Leila C/O PMV PHARMACEUTICALS, INC. 8 CLARKE DRIVE, SUITE 3 CRANBURY NJ 08512 0 1 0 0 Chief Medical Officer Common Stock 2021-09-07 4 M 0 3900 3.90 A 3900 D Common Stock 2021-09-07 4 S 0 3900 30.25 D 0 D Employee Stock Option (right to buy) 3.90 2021-09-07 4 M 0 3900 0.00 D 2030-02-04 Common Stock 3900 353950 D The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 30, 2020. One-fourth of the shares subject to the option vested on December 3, 2020, and one forty-eighth of the shares subject to the option shall vest each month thereafter. /s/ Winston Kung, by power of attorney 2021-09-08